The ALDX Stock Puzzle: Unraveling Aldeyra Therapeutics Inc’s Fluctuating Performance

Currently, the stock price of Aldeyra Therapeutics Inc (ALDX) is $2.85. In the most recent trading session, the stock underwent a significant upswing, peaking at $2.93 after opening at $2.50. The stock touched a low of $2.483 before closing at $2.49.

Aldeyra Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $11.97 on 06/15/23, with the lowest value being $1.42 on 10/16/23.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


52-week price history of ALDX Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Aldeyra Therapeutics Inc’s current trading price is -76.19% away from its 52-week high, while its distance from the 52-week low is 100.70%. The stock’s price range during this period has fluctuated between $1.42 and $11.97. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 2.09 million for the day, which was evidently lower than the average daily volume of 2.45 million over the last three months.

Financial Performance and Market Capitalization

Aldeyra Therapeutics Inc (ALDX) has experienced a quarterly decline of -61.74% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 167.64M and boasts a workforce of 15 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 5.93, with a change in price of -4.88. Similarly, Aldeyra Therapeutics Inc recorded 1,843,633 in trading volume during the last 100 days, posting a change of -63.13%.

ALDX Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ALDX stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.02.

ALDX Stock Stochastic Average

The raw stochastic average for Aldeyra Therapeutics Inc over the last 50 days is presently at 23.83%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 94.56%. Further, the company’s Stochastic %K and %D values for the last 20 days were 79.90% and 75.94%, respectively.

ALDX Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -59.05%. However, over the past six months, we’ve seen a stronger performance of -71.07%. The price of ALDX fallen by 71.69% over the last 30 days. And in the last five days, it has surged by 24.73%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts